Medline Inc. Cash & Equivalents 2022-2026 | MDLN
Beta
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Medline Inc.'s current cash & equivalents?
Medline Inc. (MDLN) annual cash & equivalents for 2025 was $1.94B, a 676.80% increase from 2024. Medline Inc. cash & equivalents for the quarter ending March 28, 2026 was $2.24B.
What was Medline Inc.'s cash & equivalents in 2024?
Medline Inc. annual cash & equivalents for 2024 was $250.0M, a 84.23% decline from 2023.
What was Medline Inc.'s cash & equivalents in 2023?
Medline Inc. annual cash & equivalents for 2023 was $1.58B, a 297.24% increase from 2022.
What is Medline Inc.'s 3-year cash & equivalents CAGR?
Medline Inc. cash & equivalents grew at a compound annual growth rate (CAGR) of 69.47% from FY2022 to FY2025, going from $399.0M to $1.94B over 3 years.
Cash & Equivalents History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+69.5%
FY2022
$399.0M
→
FY2025
$1.94B
22232425
3 years selected
Cash & Equivalents History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.94B | +676.8% | 10-K |
| FY2024 | $250.0M | -84.2% | 10-K |
| FY2023 | $1.58B | +297.2% | 10-K |
| FY2022 | $399.0M | - | 10-K |